Traitement des carcinomes de Merkel inopérables et/ou métastatiques par analogue de la somatostatine. Étude nationale multicentrique mono-bras de phase IIM.‐T. Leccia, S. Dalac, J. Dequatrebarbes et al.|Annales de Dermatologie et de Vénéréologie|2018Cited by 7
Avelumab as second-line or later (2L+) treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Analysis of real-world outcomes in France using the CARADERM registry and the French national healthcare database.A. Blom Fily, Philippe Saïag, M. Samimi et al.|Journal of Clinical Oncology|2023Cited by 3
List of critical drugs in dermatology: results of a Delphi consensus in FranceG. Chaby, M. Schöllhammer, M. Samimi et al.|British Journal of Dermatology|2024Cited by 1